Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38623 |
Ifidancitinib
ATI-502,ATI-50002 |
Others | Others |
Ifidancitinib, a potent and selective inhibitor of JAK kinases 1/3, is utilized in the research of allergies, asthma, and autoimmune diseases. | |||
T38624 |
Fosifidancitinib
|
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
Fosifidancitinib 是有效的JAK 激酶 1/3 选择性抑制剂。它在过敏、哮喘和自身免疫性疾病中有研究价值。 |